trofosfamide has been researched along with Sarcoma, Ewing in 2 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 1 (50.00) | 29.6817 |
| 2010's | 1 (50.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Bilska, K; Raciborska, A; Rodriguez-Galindo, C | 1 |
| Göbel, U; Laws, HJ; Pape, H; Paulussen, M; van Kaick, B | 1 |
2 other study(ies) available for trofosfamide and Sarcoma, Ewing
| Article | Year |
|---|---|
Maintenance treatment with trofosfamide in patients with primary bone ewing sarcoma - single center experience.
Topics: Adolescent; Antineoplastic Agents, Alkylating; Bone Neoplasms; Child; Child, Preschool; Cyclophosphamide; Female; Humans; Male; Sarcoma, Ewing; Treatment Outcome; Young Adult | 2019 |
Relapse after high-dose therapy in relapsed Ewing's tumor patients: effects of maintenance chemotherapy in two selected patients?
Topics: Adolescent; Antineoplastic Combined Chemotherapy Protocols; Bone Marrow Transplantation; Bone Neoplasms; Child; Combined Modality Therapy; Cyclophosphamide; Disease-Free Survival; Dose-Response Relationship, Drug; Etoposide; Female; Follow-Up Studies; Hematopoietic Stem Cell Transplantation; Humans; Neoplasm Recurrence, Local; Neoplasms, Multiple Primary; Radiotherapy Dosage; Radiotherapy, Adjuvant; Retreatment; Sarcoma, Ewing | 2003 |